See Young Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
See Young Lee has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Jae Hee Cho
Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Republic of Korea
9 shared publications - Sung Ill Jang
Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Republic of Korea
9 shared publications - Dong Ki Lee
Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
5 shared publications - Ji Hae Nahm
Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Republic of Korea
4 shared publications - Hye Sun Lee
Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
3 shared publications - Jung Hyun Jo
Division of Gastroenterology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Republic of Korea
3 shared publications
Latest Publications
- Open Access
- 31 July 2026
- Published by Korean Pancreatobiliary Association in The Korean Journal of Pancreas and Biliary Tract
- Vol. 31 (3) , 117-125
Efficacy and Safety of a Novel Guidewire for Selective Biliary Cannulation: A Multicenter, Prospective Randomized Controlled Study
Background/Aims: Guidewire selection is critical for endoscopic retrograde cholangiopancreatography (ERCP) in pancreatobiliary diseases. Our study evaluated the noninferiority of novel guidewire compared with conventional guidewire that is widely used in clinical practice.Methods: A total of 198 patients with a native papilla undergoing ERCP at three tertiary hospitals were randomized in a 1:1 ratio to the test or control group. The primary endpoint was the selective biliary cannulation success rate. The secondary endpoints were the cannulation time, the incidence of difficult cannulation, and adverse events, including post-ERCP pancreatitis (PEP). Difficult cannulation was defined as a cannulation time of >5 minutes, more than five cannulation attempts, or at least one unintentional pancreatic duct cannulation.Results: Among 198 patients analyzed (test: 98; control: 100), baseline characteristics were comparable. Selective biliary cannulation success was 99.0% in the test group and 96.0% in the control group; the between-group difference was 3.0 percentage points (95% CI, -2.2 to 8.9), with the lower CI bound above the prespecified -11% non-inferiority margin. PEP incidence was similar between groups (5.1% vs. 4.0%, p=0.746). However, difficult cannulation occurred more frequently in the test group than in the control group (29.6% vs. 15.0%; p=0.017), and the cannulation time was longer in the test group (5.7 vs. 3.4 minutes; p=0.011).Conclusions: The novel guidewire met the prespecified non-inferiority criterion for selective biliary cannulation success compared with the conventional guidewire. Adverse event rates, including PEP, were similar between the groups. The novel guidewire was associated with a longer cannulation time.
- 31 July 2026
- Published by Korean Pancreatobiliary Association in The Korean Journal of Pancreas and Biliary Tract
- Vol. 31 (3) , 117-125
Open AccessEfficacy and Safety of a Novel Guidewire for Selective Biliary Cannulation: A Multicenter, Prospective Randomized Controlled Study
Background/Aims: Guidewire selection is critical for endoscopic retrograde cholangiopancreatography (ERCP) in pancreatobiliary diseases. Our study evaluated the noninferiority of novel guidewire compared with conventional guidewire that is widely used in clinical practice.Methods: A total of 198 patients with a native papilla undergoing ERCP at three tertiary hospitals were randomized in a 1:1 ratio to the test or control group. The primary endpoint was the selective biliary cannulation success rate. The secondary endpoints were the cannulation time, the incidence of difficult cannulation, and adverse events, including post-ERCP pancreatitis (PEP). Difficult cannulation was defined as a cannulation time of >5 minutes, more than five cannulation attempts, or at least one unintentional pancreatic duct cannulation.Results: Among 198 patients analyzed (test: 98; control: 100), baseline characteristics were comparable. Selective biliary cannulation success was 99.0% in the test group and 96.0% in the control group; the between-group difference was 3.0 percentage points (95% CI, -2.2 to 8.9), with the lower CI bound above the prespecified -11% non-inferiority margin. PEP incidence was similar between groups (5.1% vs. 4.0%, p=0.746). However, difficult cannulation occurred more frequently in the test group than in the control group (29.6% vs. 15.0%; p=0.017), and the cannulation time was longer in the test group (5.7 vs. 3.4 minutes; p=0.011).Conclusions: The novel guidewire met the prespecified non-inferiority criterion for selective biliary cannulation success compared with the conventional guidewire. Adverse event rates, including PEP, were similar between the groups. The novel guidewire was associated with a longer cannulation time.
- Open Access
- 4 June 2026
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 14 (1) , e87368
Improving Radiology Report Error Detection Using a Multipass Large Language Model: Framework Development and Validation
Background: Large language model (LLM) proofreaders for radiology reports generate many false positives (FPs) due to the low prevalence of errors. Objective: This study aimed to determine whether an optimized LLM framework could improve both precision and cost-efficiency without compromising error detection capability. Methods: In this retrospective study, 1000 radiology reports (radiography, ultrasonography, computed tomography, and magnetic resonance imaging; 250 each) were sampled from the Medical Information Mart for Intensive Care III database. Two public chest radiography corpora (CheXpert and Open-i) served as external test sets. Three LLM frameworks were evaluated: single-prompt detector (framework 1); report extractor plus single-prompt detector (framework 2); and extractor, detector, and FP verifier (framework 3). Precision for each framework was assessed using positive predictive value (PPV) and detected errors per 1000 reports. Overall efficiency was estimated using model inference costs and reviewer labor costs. Results: PPV increased from 0.063 (95% CI 0.036‐0.101) in framework 1 to 0.079 (95% CI 0.049‐0.118) in framework 2 and 0.159 (95% CI 0.090‐0.252) in framework 3 ( P <.001). Despite improved PPV, detected errors remained stable (detected errors per 1000 reports: 12‐14). Human review burden decreased from 192 to 88 reports. Framework 3 also reduced model inference costs to US $5.57 per 1000 reports (vs US $9.72 and US $6.85 for frameworks 1 and 2; 42.6% and 18.5% reductions, respectively). External validation confirmed similar improvements. Qualitative analysis revealed that remaining FPs in framework 3 were largely confined to cases requiring deep clinical context (clinically equivalent rephrasing: 53%; unsupported discrepancy assertions: 43%). By eliminating structural FPs (eg, section mismatches and lexical errors: 0%), the framework effectively shifted the quality assurance burden to a smaller set of ambiguous cases, enabling a targeted human-in-the-loop workflow. Conclusions: The multipass LLM improved the precision and cost-efficiency of radiology report error detection in real-world, low-error prevalence settings. The framework demonstrates the feasibility of synergistic artificial intelligence–radiologist collaboration and provides a cost-effective and scalable approach to artificial intelligence–assisted quality assurance in both radiological practice and research.
- 4 June 2026
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 14 (1) , e87368
Open AccessImproving Radiology Report Error Detection Using a Multipass Large Language Model: Framework Development and Validation
Background: Large language model (LLM) proofreaders for radiology reports generate many false positives (FPs) due to the low prevalence of errors. Objective: This study aimed to determine whether an optimized LLM framework could improve both precision and cost-efficiency without compromising error detection capability. Methods: In this retrospective study, 1000 radiology reports (radiography, ultrasonography, computed tomography, and magnetic resonance imaging; 250 each) were sampled from the Medical Information Mart for Intensive Care III database. Two public chest radiography corpora (CheXpert and Open-i) served as external test sets. Three LLM frameworks were evaluated: single-prompt detector (framework 1); report extractor plus single-prompt detector (framework 2); and extractor, detector, and FP verifier (framework 3). Precision for each framework was assessed using positive predictive value (PPV) and detected errors per 1000 reports. Overall efficiency was estimated using model inference costs and reviewer labor costs. Results: PPV increased from 0.063 (95% CI 0.036‐0.101) in framework 1 to 0.079 (95% CI 0.049‐0.118) in framework 2 and 0.159 (95% CI 0.090‐0.252) in framework 3 ( P <.001). Despite improved PPV, detected errors remained stable (detected errors per 1000 reports: 12‐14). Human review burden decreased from 192 to 88 reports. Framework 3 also reduced model inference costs to US $5.57 per 1000 reports (vs US $9.72 and US $6.85 for frameworks 1 and 2; 42.6% and 18.5% reductions, respectively). External validation confirmed similar improvements. Qualitative analysis revealed that remaining FPs in framework 3 were largely confined to cases requiring deep clinical context (clinically equivalent rephrasing: 53%; unsupported discrepancy assertions: 43%). By eliminating structural FPs (eg, section mismatches and lexical errors: 0%), the framework effectively shifted the quality assurance burden to a smaller set of ambiguous cases, enabling a targeted human-in-the-loop workflow. Conclusions: The multipass LLM improved the precision and cost-efficiency of radiology report error detection in real-world, low-error prevalence settings. The framework demonstrates the feasibility of synergistic artificial intelligence–radiologist collaboration and provides a cost-effective and scalable approach to artificial intelligence–assisted quality assurance in both radiological practice and research.
- Open Access
- 10 November 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Improving Radiology Report Error Detection Using a Multi-Pass LLM Framework (Preprint)
BACKGROUND Large language model (LLM) proofreaders for radiology reports generate many false positives (FP) due to the low prevalence of errors. OBJECTIVE This study aimed to determine whether an optimized LLM framework could improve both precision and cost-efficiency without compromising error detection capability. METHODS In this retrospective study, 1,000 radiology reports (radiography, ultrasonography, CT, and MRI; 250 each) were sampled from the Medical Information Mart for Intensive Care III (MIMIC-III) database. Two public chest radiography corpora (CheXpert and Open-i) served as external test sets. Three LLM frameworks were evaluated: single-prompt detector (Framework 1); report extractor plus single-prompt detector (Framework 2); and extractor, detector, and false positive verifier (Framework 3). Precision for each framework was assessed using positive predictive value (PPV) and detected errors per 1,000 reports (DE/1k). Overall efficiency was estimated using model inference computational costs. RESULTS PPV increased from 0.063 [95% CI, 0.036–0.101] in Framework 1 to 0.079 (0.049–0.118) in Framework 2 and 0.159 (0.090–0.252) in Framework 3 (P<.001). Despite improved PPV, detected errors remained stable (DE/1k: 12–14). Human review burden decreased from 192 to 88 reports. Framework 3 also reduced costs to $5.58 per 1,000 reports (vs $9.72 and $6.85 for Frameworks 1 and 2; 42.6% and 18.5% reductions). External validation confirmed similar improvements. CONCLUSIONS A three-pass LLM framework more than doubled precision and halved the cost of radiology report error detection without compromising error detection capability, offering sustainable strategies for AI-assisted quality assurance in both radiological practice and research.
- 10 November 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessImproving Radiology Report Error Detection Using a Multi-Pass LLM Framework (Preprint)
BACKGROUND Large language model (LLM) proofreaders for radiology reports generate many false positives (FP) due to the low prevalence of errors. OBJECTIVE This study aimed to determine whether an optimized LLM framework could improve both precision and cost-efficiency without compromising error detection capability. METHODS In this retrospective study, 1,000 radiology reports (radiography, ultrasonography, CT, and MRI; 250 each) were sampled from the Medical Information Mart for Intensive Care III (MIMIC-III) database. Two public chest radiography corpora (CheXpert and Open-i) served as external test sets. Three LLM frameworks were evaluated: single-prompt detector (Framework 1); report extractor plus single-prompt detector (Framework 2); and extractor, detector, and false positive verifier (Framework 3). Precision for each framework was assessed using positive predictive value (PPV) and detected errors per 1,000 reports (DE/1k). Overall efficiency was estimated using model inference computational costs. RESULTS PPV increased from 0.063 [95% CI, 0.036–0.101] in Framework 1 to 0.079 (0.049–0.118) in Framework 2 and 0.159 (0.090–0.252) in Framework 3 (P<.001). Despite improved PPV, detected errors remained stable (DE/1k: 12–14). Human review burden decreased from 192 to 88 reports. Framework 3 also reduced costs to $5.58 per 1,000 reports (vs $9.72 and $6.85 for Frameworks 1 and 2; 42.6% and 18.5% reductions). External validation confirmed similar improvements. CONCLUSIONS A three-pass LLM framework more than doubled precision and halved the cost of radiology report error detection without compromising error detection capability, offering sustainable strategies for AI-assisted quality assurance in both radiological practice and research.
- Open Access
- 20 August 2025
- Published by Korean Society of Gastrointestinal Cancer Research in Journal of Digestive Cancer Research
- Vol. 13 (2) , 120-130
Diagnosis and Management of Intraductal Papillary Mucinous Neoplasms: Focusing on Precancerous Lesions
See Young Lee, Chan Min Jung, Jung Hyun Jo, Sung Ill Jang, Jae Hee Cho. Journal of Digestive Cancer Research 2025;13:120-30. https://doi.org/10.52927/jdcr.2025.13.2.120
- 20 August 2025
- Published by Korean Society of Gastrointestinal Cancer Research in Journal of Digestive Cancer Research
- Vol. 13 (2) , 120-130
Open AccessDiagnosis and Management of Intraductal Papillary Mucinous Neoplasms: Focusing on Precancerous Lesions
See Young Lee, Chan Min Jung, Jung Hyun Jo, Sung Ill Jang, Jae Hee Cho. Journal of Digestive Cancer Research 2025;13:120-30. https://doi.org/10.52927/jdcr.2025.13.2.120
- Open Access
- 25 July 2025
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (3) , 483-496
Disulfiram/Copper Complex Induces Cytotoxicity in Pancreatic Cancer Cells and 5-Fluorouracil-Resistant Cells through Nuclear Factor E2-Related Factor-2 Suppression and Reactive Oxygen Species Modulation
Pancreatic ductal adenocarcinoma (PDAC) is a challenging cancer to treat and has a poor prognosis and limited treatment options. In this study, the anticancer effects of disulfiram combined with copper (DSF/Cu) on PDAC cells, including those resistant to 5-fluorouracil, was assessed. Human pancreatic cancer cells (BxPC-3 and CFPAC-1) and their 5-fluorouracil-resistant (5FUR) counterparts were treated with DSF/Cu to assess cytotoxicity. Expression levels of nuclear factor E2-related factor-2 (NRF-2) and heme oxygenase-1 (HO-1) were analyzed by reverse transcription quantitative polymerase chain reaction and Western blotting, while intracellular reactive oxygen species (ROS) levels were evaluated using H2DCFDA staining and flow cytometry. The effects of DSF/Cu on protein kinase B (Akt) and mitogen-activated protein kinase (MAPK) signaling pathways were evaluated by Western blot analysis. In vivo efficacy was investigated using a xenograft mouse model, in which mice were orally administered DSF (75 mg/kg) and Cu (2 mg/kg) twice weekly for 5 weeks. We demonstrated that DSF/Cu effectively induced cytotoxicity in both pancreatic cancer cells and their 5FUR counterparts by modulating ROS levels, NRF-2 levels, and associated survival pathways. DSF/Cu treatment significantly decreased NRF-2 expression and reduced ROS levels, specifically in 5FUR cells. DSF/Cu facilitated NRF-2-independent HO-1 expression and differentially modulated Akt and MAPK signaling pathways in pancreatic cancer cells and their 5FUR counterparts. In vivo studies using a xenograft mouse model confirmed the antitumor efficacy of DSF/Cu, as evidenced by reduced tumor volumes and NRF-2 expression. These findings highlight the potential of DSF/Cu as a novel and effective therapeutic strategy for PDAC, specifically for overcoming resistance to standard therapies.
- 25 July 2025
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (3) , 483-496
Open AccessDisulfiram/Copper Complex Induces Cytotoxicity in Pancreatic Cancer Cells and 5-Fluorouracil-Resistant Cells through Nuclear Factor E2-Related Factor-2 Suppression and Reactive Oxygen Species Modulation
Pancreatic ductal adenocarcinoma (PDAC) is a challenging cancer to treat and has a poor prognosis and limited treatment options. In this study, the anticancer effects of disulfiram combined with copper (DSF/Cu) on PDAC cells, including those resistant to 5-fluorouracil, was assessed. Human pancreatic cancer cells (BxPC-3 and CFPAC-1) and their 5-fluorouracil-resistant (5FUR) counterparts were treated with DSF/Cu to assess cytotoxicity. Expression levels of nuclear factor E2-related factor-2 (NRF-2) and heme oxygenase-1 (HO-1) were analyzed by reverse transcription quantitative polymerase chain reaction and Western blotting, while intracellular reactive oxygen species (ROS) levels were evaluated using H2DCFDA staining and flow cytometry. The effects of DSF/Cu on protein kinase B (Akt) and mitogen-activated protein kinase (MAPK) signaling pathways were evaluated by Western blot analysis. In vivo efficacy was investigated using a xenograft mouse model, in which mice were orally administered DSF (75 mg/kg) and Cu (2 mg/kg) twice weekly for 5 weeks. We demonstrated that DSF/Cu effectively induced cytotoxicity in both pancreatic cancer cells and their 5FUR counterparts by modulating ROS levels, NRF-2 levels, and associated survival pathways. DSF/Cu treatment significantly decreased NRF-2 expression and reduced ROS levels, specifically in 5FUR cells. DSF/Cu facilitated NRF-2-independent HO-1 expression and differentially modulated Akt and MAPK signaling pathways in pancreatic cancer cells and their 5FUR counterparts. In vivo studies using a xenograft mouse model confirmed the antitumor efficacy of DSF/Cu, as evidenced by reduced tumor volumes and NRF-2 expression. These findings highlight the potential of DSF/Cu as a novel and effective therapeutic strategy for PDAC, specifically for overcoming resistance to standard therapies.
- Open Access
- 15 July 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (14) , 1783
A New Staining Method Using Methionyl-tRNA Synthetase 1 Antibody for Endoscopic Ultrasound-Guided Fine-Needle Aspiration Cytology of Pancreatic Cancer
Background/Objectives: Accurate determination of malignancy in pancreatic masses through endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is crucial for appropriate clinical management and prognostic assessment. However, the diagnostic sensitivity of conventional cytology using Papanicolaou (Pap) staining remains limited, often leading to inconclusive results. In this study, we investigated the diagnostic utility of methionyl-tRNA synthetase 1 (MARS1) through immunohistochemical (IHC) and immunofluorescence (IF) staining as a potential biomarker for pancreatic cancer. IHC analysis was conducted on resected tissue samples from 10 patients, including both pancreatic ductal adenocarcinoma and corresponding non-neoplastic pancreatic tissue. Additionally, cytologic samples were obtained from 198 patients with pancreatic masses who underwent EUS-FNA for diagnostic evaluation. Pap staining and MARS1 IF staining were performed on liquid-based cytology slides derived from EUS-FNA specimens. Results: MARS1 was detected by IHC staining in the 10 surgical specimens diagnosed with pancreatic adenocarcinomas. After Pap staining, 37 patients were excluded because of unsuitable specimens, leaving 161 patients who underwent both Pap and MARS1 IF staining. EUS-FNA specimens from the 151 patients with pancreatic ductal adenocarcinoma were classified by Pap staining as atypia (n = 36), suspicious for malignancy (n = 55), or malignancy (n = 60). MARS1 IF staining was positive in 147 of these patients and negative in 4. MARS1 IF staining distinguished pancreatic cancer in specimens with atypia on Pap staining. The sensitivity for detecting pancreatic cancer was significantly higher for MARS1 IF staining than for conventional Pap staining (97.4% vs. 79.1%, p < 0.0001). Conclusions: The high sensitivity of MARS1 IF staining improved malignancy detection in pancreatic masses. Further prospective studies are required to validate our findings.
- 15 July 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (14) , 1783
Open AccessA New Staining Method Using Methionyl-tRNA Synthetase 1 Antibody for Endoscopic Ultrasound-Guided Fine-Needle Aspiration Cytology of Pancreatic Cancer
Background/Objectives: Accurate determination of malignancy in pancreatic masses through endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is crucial for appropriate clinical management and prognostic assessment. However, the diagnostic sensitivity of conventional cytology using Papanicolaou (Pap) staining remains limited, often leading to inconclusive results. In this study, we investigated the diagnostic utility of methionyl-tRNA synthetase 1 (MARS1) through immunohistochemical (IHC) and immunofluorescence (IF) staining as a potential biomarker for pancreatic cancer. IHC analysis was conducted on resected tissue samples from 10 patients, including both pancreatic ductal adenocarcinoma and corresponding non-neoplastic pancreatic tissue. Additionally, cytologic samples were obtained from 198 patients with pancreatic masses who underwent EUS-FNA for diagnostic evaluation. Pap staining and MARS1 IF staining were performed on liquid-based cytology slides derived from EUS-FNA specimens. Results: MARS1 was detected by IHC staining in the 10 surgical specimens diagnosed with pancreatic adenocarcinomas. After Pap staining, 37 patients were excluded because of unsuitable specimens, leaving 161 patients who underwent both Pap and MARS1 IF staining. EUS-FNA specimens from the 151 patients with pancreatic ductal adenocarcinoma were classified by Pap staining as atypia (n = 36), suspicious for malignancy (n = 55), or malignancy (n = 60). MARS1 IF staining was positive in 147 of these patients and negative in 4. MARS1 IF staining distinguished pancreatic cancer in specimens with atypia on Pap staining. The sensitivity for detecting pancreatic cancer was significantly higher for MARS1 IF staining than for conventional Pap staining (97.4% vs. 79.1%, p < 0.0001). Conclusions: The high sensitivity of MARS1 IF staining improved malignancy detection in pancreatic masses. Further prospective studies are required to validate our findings.
- Open Access
- 1 March 2025
- Published by KEAI Publishing in Magnetic Medicine
- Vol. 1 (1)
Magnetic compression anastomosis in managing refractory biliary strictures following multiple surgical interventions: a comprehensive review
- 1 March 2025
- Published by KEAI Publishing in Magnetic Medicine
- Vol. 1 (1)
Open AccessMagnetic compression anastomosis in managing refractory biliary strictures following multiple surgical interventions: a comprehensive review
- Open Access
- 8 November 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (22) , 6741
The Catheter Flushing Method Shows a Similar Diagnostic Yield to the Conventional Method in Brushing Cytology for Biliary Strictures
Background/Objectives: Endobiliary brushing is usually performed in the diagnosis of indeterminate biliary strictures; however, in this setting, brush cytology is limited by a low diagnostic yield and sensitivity. Here, we compared the catheter flushing method (CFM) with the conventional cytologic method (CCM) in terms of cellularity and diagnostic performance. Methods: Endobiliary brushings were obtained during endoscopic retrograde cholangiopancreatography (ERCP) from patients with biliary strictures enrolled at six tertiary hospitals. Additionally, the CFM was performed after brushing. Using liquid-based cytologic preparations of samples, we assessed the diagnostic performance of the CCM using Pap staining and the CFM using methionyl-transfer RNA synthetase 1 (MARS1) immunofluorescence staining. Results: From a total of 399 patients (malignant, 253; benign, 146), 374 CCM samples and 361 CFM samples contained adequate cells, with no significant difference in diagnostic yield (93.7% vs. 90.5%, respectively; p = 0.088). The sensitivity of the CFM (90.3%) was significantly higher than that of the CCM (75.1%; p < 0.001), with no significant difference in accuracy between methods (81.2% vs. 82.6%, respectively; p = 0.608). Conclusions: The diagnostic yield of the CFM was comparable to that of the CCM. Additionally, the diagnostic performance of the CFM was comparable to that of the CCM. These findings indicate that the CFM could be an additional brush cytology method for sample collection in patients with indeterminate biliary strictures. Incorporating both the CCM and CFM might be expected to improve the diagnostic yield of brush cytology in the biliary strictures. Further prospective comparative studies between the CCM and CFM using the same staining method are needed to validate these findings.
- 8 November 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (22) , 6741
Open AccessThe Catheter Flushing Method Shows a Similar Diagnostic Yield to the Conventional Method in Brushing Cytology for Biliary Strictures
Background/Objectives: Endobiliary brushing is usually performed in the diagnosis of indeterminate biliary strictures; however, in this setting, brush cytology is limited by a low diagnostic yield and sensitivity. Here, we compared the catheter flushing method (CFM) with the conventional cytologic method (CCM) in terms of cellularity and diagnostic performance. Methods: Endobiliary brushings were obtained during endoscopic retrograde cholangiopancreatography (ERCP) from patients with biliary strictures enrolled at six tertiary hospitals. Additionally, the CFM was performed after brushing. Using liquid-based cytologic preparations of samples, we assessed the diagnostic performance of the CCM using Pap staining and the CFM using methionyl-transfer RNA synthetase 1 (MARS1) immunofluorescence staining. Results: From a total of 399 patients (malignant, 253; benign, 146), 374 CCM samples and 361 CFM samples contained adequate cells, with no significant difference in diagnostic yield (93.7% vs. 90.5%, respectively; p = 0.088). The sensitivity of the CFM (90.3%) was significantly higher than that of the CCM (75.1%; p < 0.001), with no significant difference in accuracy between methods (81.2% vs. 82.6%, respectively; p = 0.608). Conclusions: The diagnostic yield of the CFM was comparable to that of the CCM. Additionally, the diagnostic performance of the CFM was comparable to that of the CCM. These findings indicate that the CFM could be an additional brush cytology method for sample collection in patients with indeterminate biliary strictures. Incorporating both the CCM and CFM might be expected to improve the diagnostic yield of brush cytology in the biliary strictures. Further prospective comparative studies between the CCM and CFM using the same staining method are needed to validate these findings.
- 24 September 2024
- Published by Elsevier in Pancreatology
- Vol. 24 (7) , 1003-1011
Oral high-carbohydrate solution as an alternative dietary modality in patients with acute pancreatitis
- 24 September 2024
- Published by Elsevier in Pancreatology
- Vol. 24 (7) , 1003-1011
Oral high-carbohydrate solution as an alternative dietary modality in patients with acute pancreatitis
- Open Access
- 7 May 2024
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 18 (6) , 1069-1079
Gallstone Dissolution Effects of Combination Therapy with n-3 Polyunsaturated Fatty Acids and Ursodeoxycholic Acid: A Randomized, Prospective, Preliminary Clinical Trial
See Young Lee, Sung Ill Jang, Jae Hee Cho, Min Young Do, Su Yeon Lee, Arong Choi, Hye Sun Lee, Juyeon Yang, Dong Ki Lee. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl230494
- 7 May 2024
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 18 (6) , 1069-1079
Open AccessGallstone Dissolution Effects of Combination Therapy with n-3 Polyunsaturated Fatty Acids and Ursodeoxycholic Acid: A Randomized, Prospective, Preliminary Clinical Trial
See Young Lee, Sung Ill Jang, Jae Hee Cho, Min Young Do, Su Yeon Lee, Arong Choi, Hye Sun Lee, Juyeon Yang, Dong Ki Lee. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl230494